A Study to Evaluate the Efficacy and Safety of DA-5204

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the non-inferiority of DA-5204 compared with Stillen® tab. in patients with acute or chronic gastritis.
Epistemonikos ID: 531f105a2a7db70be719a1ff81419027251ff234
First added on: May 12, 2024